Clinical Trials Logo
  1. Home
  2. Acute
  3. NCT00502385

Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML

Acute Clinical Trial

Clinical Trial Summary

The study will be conducted across multiple European centres to assess the safety and tolerability of multiple doses of AZD2171 in patients with AML.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00502385
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 1
Start date April 2004
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05734976 - Electroacupuncture on Modifying Inflammatory Levels of Cytokines and Metabolites in Stroke Patients. N/A
Completed NCT03516175 - Pre-oxygenation With High-flow Nasal Cannula in Adults During Rapid Sequence Induction Anesthesia N/A
Active, not recruiting NCT01152424 - Usefulness of Exhaled NO in the Differential Diagnosis Acute Eosinophilic Pneumonia and Bacterial Pneumonia N/A
Completed NCT01193413 - Soluble Triggering Receptor Expressed on Myeloid Cells in Severe Acute Pancreatitis N/A
Not yet recruiting NCT01227863 - Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis Phase 3
Recruiting NCT05673057 - Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Phase 1/Phase 2
Completed NCT04051658 - Hemodynamic Response and Motor Functions Following Transcranial Direct Current Stimulation in Acute Stroke N/A
Recruiting NCT05551923 - Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral Hemorrhage
Completed NCT03968185 - Interfascial Infiltration for Acute Unspecific Low Back Pain in the Emergency Department